Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Fidelity® Select Biotechnology Portfolio (FBIOX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.65 -0.29    -1.38%
26/11 - Closed. Currency in USD ( Disclaimer )
Type:  Fund
Market:  United States
Issuer:  Fidelity Investments
ISIN:  US3163907724 
S/N:  316390772
Underlying:  S&P 500 TR
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 8.87B
Fidelity Select Biotechnology 20.65 -0.29 -1.38%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Rating
1-Year Change - 20.95%
Prev. Close20.94
Risk Rating
TTM Yield0.16%
ROE - 12.33%
IssuerFidelity Investments
Turnover41%
ROA - 16.81%
Inception DateDec 16, 1985
Total Assets8.87B
Expenses0.68%
Min. Investment2,500
Market Cap7.08B
CategoryHealth
What is your sentiment on Fidelity Select Biotechnology?
or
Market is currently closed. Voting is open during market hours.

Fidelity® Select Biotechnology Portfolio Analysis


Jay Kaeppel
Biotech’s Spring Into Summer Event By Jay Kaeppel - May 18, 2018 1

Okay, I suppose it would have been helpful to highlight this one a little sooner, but since the purpose of this blog is to “educate” and not to “prompt trading...

Performance

Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

YTD 3M 1Y 3Y 5Y 10Y
Growth of 1000 942 992 1140 1625 2100 5651
Fund Return -5.8% -0.81% 13.95% 17.56% 16% 18.91%
Place in category 150 132 149 64 74 15
% in Category 86 68 85 40 58 21

Top Equity Funds by Fidelity Investments

  Name Rating Total Assets YTD% 3Y% 10Y%
  Fidelity 500 Index Institutional Pr 379.81B 24.03 21.46 16.20
  Fidelity Contrafund 128.94B 22.87 25.24 17.61
  Fidelity Contrafund K 128.94B 22.87 25.34 17.72
  Fidelity Total Market Index Instl b 74.89B 22.86 21.58 16.05
  Strategic Advisers Core 63.38B 24.48 21.70 15.73

Top Funds for Health Category

  Name Rating Total Assets YTD% 3Y% 10Y%
  Vanguard Health Care Adm 43.52B 12.17 14.39 15.38
  T. Rowe Price Health Sciences 17.09B 15.62 21.79 21.25
  Fidelity Select Medical Equip & Sy 11.04B 27.01 27.22 22.12
  Fidelity Select Health Care 10.35B 13.01 20.22 19.81
  Vanguard Health Care Inv 8.13B 12.12 14.34 15.32

Top Holdings

Name ISIN Weight % Last Change %
Moderna Inc - 5.21 - -
AbbVie Inc - 4.59 - -
Alnylam Pharmaceuticals Inc - 3.51 - -
Biogen Inc - 3.35 - -
Gilead Sciences Inc - 3.04 - -

Technical Summary

Type Daily Weekly Monthly
Moving Averages Strong Sell Strong Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FBIOX Comments

Write your thoughts about Fidelity® Select Biotechnology Portfolio
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email